Id |
Subject |
Object |
Predicate |
Lexical cue |
T2466 |
176-182 |
Entity |
denotes |
Silber |
T2488 |
346-360 |
Entity |
denotes |
Friedman et al |
T2463 |
502-512 |
Entity |
denotes |
Haar et al |
T2465 |
654-708 |
Entity |
denotes |
the monofunctional alkylating agent temozolomide (TMZ) |
T2400 |
673-689 |
Entity |
denotes |
alkylating agent |
T2391 |
704-707 |
Entity |
denotes |
TMZ |
T2456 |
791-794 |
Entity |
denotes |
TMZ |
T2438 |
825-854 |
Entity |
denotes |
cancer stem cells, microRNAs, |
T2373 |
855-859 |
Entity |
denotes |
drug |
T2412 |
868-871 |
Entity |
denotes |
DNA |
T2429 |
887-994 |
Entity |
denotes |
tumor cells under hypoxia, histone deacetylation, epithelial-mesenchymal transition, STAT3 kinase, and many |
T2399 |
972-977 |
Protein |
denotes |
STAT3 |
T2405 |
972-984 |
Protein |
denotes |
STAT3 kinase |
T2476 |
1142-1154 |
Entity |
denotes |
Temozolomide |
T2377 |
1174-1189 |
Entity |
denotes |
of DNA lesions, |
T2392 |
1200-1216 |
Entity |
denotes |
O6-methylguanine |
T2378 |
1200-1216 |
Entity |
denotes |
O6-methylguanine |
T2360 |
1218-1234 |
Entity |
denotes |
N3-methyladenine |
T2444 |
1240-1256 |
Entity |
denotes |
N7-methylguanine |
T2384 |
1240-1256 |
Entity |
denotes |
N7-methylguanine |
T2481 |
1303-1330 |
Entity |
denotes |
The O6-methylguanine lesion |
T2389 |
1303-1330 |
Entity |
denotes |
The O6-methylguanine lesion |
T2498 |
1435-1483 |
Negative_regulation |
denotes |
inhibition of antiapoptotic Bcl-2 by a pan-Bcl-2 |
T2366 |
1446-1468 |
Protein |
denotes |
of antiapoptotic Bcl-2 |
T2464 |
1469-1483 |
Protein |
denotes |
by a pan-Bcl-2 |
T2428 |
1484-1497 |
Entity |
denotes |
inhibitor (−) |
T2420 |
1484-1506 |
Entity |
denotes |
inhibitor (−)-gossypol |
T2451 |
1568-1574 |
Entity |
denotes |
of TMZ |
T2480 |
1638-1649 |
Entity |
denotes |
TMZ-induced |
T2401 |
1717-1750 |
Entity |
denotes |
GBM cells (Knizhnik et al., 2013) |
T2417 |
1758-1774 |
Protein |
denotes |
MAPO2 (C1orf201) |
T2411 |
1758-1779 |
Protein |
denotes |
MAPO2 (C1orf201) gene |
T2419 |
1765-1773 |
Protein |
denotes |
C1orf201 |
T2445 |
1800-1831 |
Entity |
denotes |
O6-methylguanine lesion-induced |
T2364 |
1800-1831 |
Entity |
denotes |
O6-methylguanine lesion-induced |
T2485 |
1867-1872 |
Protein |
denotes |
MAPO2 |
T2359 |
1867-1877 |
Protein |
denotes |
MAPO2 gene |
T2500 |
1867-1908 |
Regulation |
denotes |
MAPO2 gene encodes a novel 37-kDa protein |
T2474 |
1886-1908 |
Protein |
denotes |
a novel 37-kDa protein |
T2381 |
1939-1948 |
Protein |
denotes |
this gene |
T2461 |
1975-2002 |
Entity |
denotes |
The O6-methylguanine lesion |
T2450 |
1975-2002 |
Entity |
denotes |
The O6-methylguanine lesion |
T2468 |
2006-2084 |
Entity |
denotes |
a substrate for direct repair by O6-methylguanine-DNA methyltransferase (MGMT) |
T2475 |
2036-2084 |
Protein |
denotes |
by O6-methylguanine-DNA methyltransferase (MGMT) |
T2433 |
2079-2083 |
Protein |
denotes |
MGMT |
T2385 |
2181-2185 |
Protein |
denotes |
MGMT |
T2442 |
2194-2210 |
Entity |
denotes |
O6-methylguanine |
T2439 |
2194-2210 |
Entity |
denotes |
O6-methylguanine |
T2453 |
2267-2275 |
Protein |
denotes |
proteins |
T2426 |
2292-2352 |
Protein |
denotes |
protein kinase that ultimately leads to apoptotic cell death |
T2487 |
2402-2406 |
Protein |
denotes |
Roos |
T2446 |
2410-2412 |
Entity |
denotes |
al |
T2423 |
2441-2445 |
Protein |
denotes |
MGMT |
T2431 |
2490-2493 |
Entity |
denotes |
TMZ |
T2416 |
2529-2542 |
Entity |
denotes |
Pollack et al |
T2452 |
2660-2663 |
Protein |
denotes |
MMR |
T2421 |
2687-2690 |
Entity |
denotes |
TMZ |
T2406 |
2747-2768 |
Entity |
denotes |
of MGMT gene promoter |
T2395 |
2747-2768 |
Protein |
denotes |
of MGMT gene promoter |
T2458 |
2750-2754 |
Protein |
denotes |
MGMT |
T2477 |
2772-2777 |
Entity |
denotes |
cells |
T2501 |
2832-2878 |
Positive_regulation |
denotes |
An increase in MGMT gene promoter methylation, |
T2443 |
2844-2878 |
Protein |
denotes |
in MGMT gene promoter methylation, |
T2437 |
2847-2851 |
Protein |
denotes |
MGMT |
T2409 |
2857-2865 |
Entity |
denotes |
promoter |
T2502 |
2879-2916 |
Negative_regulation |
denotes |
which blocks MGMT protein expression, |
T2482 |
2892-2896 |
Protein |
denotes |
MGMT |
T2388 |
2892-2904 |
Protein |
denotes |
MGMT protein |
T2496 |
2892-2916 |
Gene_expression |
denotes |
MGMT protein expression, |
T2494 |
2965-2990 |
Positive_regulation |
denotes |
overexpressed microRNA-21 |
T2493 |
2965-2990 |
Gene_expression |
denotes |
overexpressed microRNA-21 |
T2407 |
2965-2990 |
Protein |
denotes |
overexpressed microRNA-21 |
T2448 |
2999-3008 |
Protein |
denotes |
Bax/Bcl-2 |
T2435 |
2999-3008 |
Protein |
denotes |
Bax/Bcl-2 |
T2375 |
3003-3008 |
Protein |
denotes |
Bcl-2 |
T2370 |
3019-3028 |
Protein |
denotes |
caspase-3 |
T2397 |
3056-3067 |
Entity |
denotes |
TMZ-induced |
T2403 |
3079-3082 |
Protein |
denotes |
Shi |
T2449 |
3098-3109 |
Protein |
denotes |
MicroRNA-21 |
T2410 |
3153-3165 |
Entity |
denotes |
cancer cells |
T2486 |
3185-3194 |
Entity |
denotes |
Integrins |
T2386 |
3314-3317 |
Protein |
denotes |
p53 |
T2499 |
3314-3327 |
Positive_regulation |
denotes |
p53 signaling |
T2390 |
3351-3362 |
Entity |
denotes |
glioma cell |
T2372 |
3377-3406 |
Entity |
denotes |
TMZ (Janouskova et al., 2012) |
T2368 |
3489-3520 |
Protein |
denotes |
The base excision repair enzyme |
T2432 |
3573-3611 |
Entity |
denotes |
the cytotoxic lesions N3-methyladenine |
T2371 |
3577-3586 |
Entity |
denotes |
cytotoxic |
T2462 |
3616-3633 |
Entity |
denotes |
N7-methylguanine, |
T2363 |
3616-3633 |
Entity |
denotes |
N7-methylguanine, |
T2414 |
3659-3662 |
Entity |
denotes |
TMZ |
T2492 |
3700-3810 |
Positive_regulation |
denotes |
Upregulation of mitochondrial respiratory chain coupling to suppress the production of reactive oxygen species |
T2497 |
3713-3756 |
Binding |
denotes |
of mitochondrial respiratory chain coupling |
T2490 |
3716-3747 |
Entity |
denotes |
mitochondrial respiratory chain |
T2495 |
3757-3810 |
Negative_regulation |
denotes |
to suppress the production of reactive oxygen species |
T2362 |
3812-3815 |
Protein |
denotes |
ROS |
T2460 |
3827-3865 |
Protein |
denotes |
by cytochrome c oxidase contributes in |
T2365 |
3843-3850 |
Protein |
denotes |
oxidase |
T2467 |
3874-3877 |
Entity |
denotes |
TMZ |
T2436 |
3934-3937 |
Entity |
denotes |
TMZ |
T2473 |
3968-3972 |
Protein |
denotes |
MGMT |
T2447 |
3968-3989 |
Entity |
denotes |
MGMT pseudosubstrates |
T2376 |
3991-4007 |
Entity |
denotes |
O6-benzylguanine |
T2472 |
4012-4023 |
Entity |
denotes |
lomeguatrib |
T2394 |
4044-4050 |
Entity |
denotes |
to TMZ |
T2379 |
4074-4118 |
Entity |
denotes |
Methoxyamine-blocker of base excision repair |
T2425 |
4148-4151 |
Entity |
denotes |
TMZ |
T2484 |
4183-4199 |
Entity |
denotes |
O6-methylguanine |
T2418 |
4183-4199 |
Entity |
denotes |
O6-methylguanine |
T2471 |
4183-4207 |
Entity |
denotes |
O6-methylguanine adducts |
T2415 |
4186-4199 |
Entity |
denotes |
methylguanine |
T2440 |
4323-4326 |
Entity |
denotes |
NAD |
T2402 |
4355-4358 |
Entity |
denotes |
TMZ |
T2367 |
4440-4461 |
Protein |
denotes |
Interferon-β (IFN-β), |
T2478 |
4440-4475 |
Entity |
denotes |
Interferon-β (IFN-β), levetiracetam |
T2361 |
4454-4459 |
Protein |
denotes |
IFN-β |
T2483 |
4483-4495 |
Entity |
denotes |
resveratrol, |
T2430 |
4500-4519 |
Entity |
denotes |
valproic acid (VAP) |
T2470 |
4515-4518 |
Protein |
denotes |
VAP |
T2469 |
4548-4551 |
Entity |
denotes |
TMZ |
T2374 |
4560-4574 |
Protein |
denotes |
MGMT-dependent |
T2427 |
4625-4659 |
Entity |
denotes |
Resveratrol, a natural polyphenol, |
T2396 |
4638-4658 |
Entity |
denotes |
a natural polyphenol |
T2404 |
4669-4672 |
Entity |
denotes |
TMZ |
T2398 |
4691-4706 |
Protein |
denotes |
NF-κB-dependent |
T2422 |
4739-4773 |
Protein |
denotes |
STAT3 inhibitor or STAT3 knockdown |
T2441 |
4745-4754 |
Entity |
denotes |
inhibitor |
T2454 |
4758-4763 |
Protein |
denotes |
STAT3 |
T2455 |
4786-4789 |
Entity |
denotes |
TMZ |
T2489 |
4936-4939 |
Entity |
denotes |
TMZ |
T2413 |
4997-5000 |
Entity |
denotes |
TMZ |
T2424 |
5021-5024 |
Protein |
denotes |
Sun |
T2383 |
5040-5057 |
Entity |
denotes |
Cancer stem cells |
T2434 |
5093-5096 |
Entity |
denotes |
TMZ |
T2382 |
5130-5139 |
Entity |
denotes |
stem cell |
T2459 |
5169-5172 |
Entity |
denotes |
TMZ |
T2491 |
5177-5205 |
Entity |
denotes |
other chemotherapeutic drugs |
T2408 |
5297-5302 |
Protein |
denotes |
CD133 |
T2479 |
5303-5329 |
Entity |
denotes |
positive cancer stem cells |
T2369 |
5352-5369 |
Entity |
denotes |
normal stem cells |
T2393 |
5374-5391 |
Entity |
denotes |
cancer stem cells |
T2457 |
5442-5450 |
Protein |
denotes |
of CD133 |
T2387 |
5467-5491 |
Entity |
denotes |
glioma cancer stem cells |
T2380 |
5504-5527 |
Entity |
denotes |
its biological function |
R1554 |
T2359 |
T2500 |
causeOf |
MAPO2 gene,MAPO2 gene encodes a novel 37-kDa protein |
R1556 |
T2366 |
T2498 |
themeOf |
of antiapoptotic Bcl-2,inhibition of antiapoptotic Bcl-2 by a pan-Bcl-2 |
R1562 |
T2386 |
T2499 |
causeOf |
p53,p53 signaling |
R1563 |
T2388 |
T2496 |
themeOf |
MGMT protein,"MGMT protein expression," |
R1568 |
T2406 |
T2458 |
partOf |
of MGMT gene promoter,MGMT |
R1569 |
T2407 |
T2493 |
themeOf |
overexpressed microRNA-21,overexpressed microRNA-21 |
R1570 |
T2407 |
T2494 |
themeOf |
overexpressed microRNA-21,overexpressed microRNA-21 |
R1571 |
T2464 |
T2498 |
causeOf |
by a pan-Bcl-2,inhibition of antiapoptotic Bcl-2 by a pan-Bcl-2 |
R1572 |
T2474 |
T2500 |
themeOf |
a novel 37-kDa protein,MAPO2 gene encodes a novel 37-kDa protein |
R1573 |
T2490 |
T2497 |
themeOf |
mitochondrial respiratory chain,of mitochondrial respiratory chain coupling |
R1574 |
T2496 |
T2502 |
themeOf |
"MGMT protein expression,","which blocks MGMT protein expression," |
R1575 |
T2497 |
T2492 |
themeOf |
of mitochondrial respiratory chain coupling,Upregulation of mitochondrial respiratory chain coupling to suppress the production of reactive oxygen species |